Related Experiment Video
Updated: May 2, 2026

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
A 'waterfall' transfer-based workflow for improved quality of tissue microarray construction and processing in breast
M Oberländer1, H Alkemade, S Bünger
1Section for Translational Surgical Oncology and Biobanking, Department of Surgery, University of Lübeck and University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
This study details a robust workflow for creating high-density breast cancer tissue microarrays (TMAs). The method ensures high-quality tissue sections for biomarker research, with over 97% core recovery after sectioning and 96% evaluability after staining.
Area of Science:
- Oncology
- Biomarker Discovery
- Pathology
Background:
- Identifying cancer biomarkers is crucial for early diagnosis, treatment selection, and prognosis.
- Tissue microarrays (TMAs) are vital for high-throughput analysis of clinical samples.
- Challenges exist in constructing and processing TMAs for reliable research.
Purpose of the Study:
- To present a robust workflow for constructing high-density breast cancer TMAs.
- To overcome obstacles in TMA construction and processing for high-quality research sections.
- To ensure sample integrity for subsequent immunohistochemistry (IHC) and immunofluorescence (IF) staining.
Main Methods:
- Constructed high-density breast cancer TMAs using 406 tissue cores from 245 patients.
- Utilized a rotary microtome with an automated transfer system for sectioning.
- Performed IHC and IF staining for nine proteins, manually assessing core quality and quantity.
Main Results:
- Achieved 97.1% core recovery after sectioning.
- Maintained 96% evaluability of remaining cores after staining.
- Observed higher loss rates in normal tissue cores compared to tumor cores.
Conclusions:
- The developed workflow enables the robust manufacturing of high-density breast cancer TMAs.
- This method minimizes sample loss, ensuring high-quality sections for IHC and IF.
- The workflow supports reliable biomarker validation in cancer research.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
09:57Workflow for High-content, Individual Cell Quantification of Fluorescent Markers from Universal Microscope Data, Supported by Open Source Software
Published on: December 16, 2014